Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Bio Rad Laboratories Inc BIO

Alternate Symbol(s):  BIO.B

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and... see more

NYSE:BIO - Post Discussion

Bio Rad Laboratories Inc > Cell Analysis Market Analysis 2022: Industry Report
View:
Post by edwardebreen15 on Aug 19, 2022 2:47am

Cell Analysis Market Analysis 2022: Industry Report

According to IMARC Group’s latest report, titled "Cell Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global cell analysis market reached a value of US$ 17.4 Billion in 2021. Cell analysis assists in the study of genetic and phenotypic properties of cells, which are isolated from tissues in multicellular and unicellular organisms. It also aids in identifying genes and protein epigenomics and understanding factors that indicate cell health, death, and proliferation. At present, it is widely utilized in medical research laboratories to identify minority sub-populations of interests, understand population heterogeneity, and discover unique characteristics of individual cells.

 

Request for a PDF sample of this report: https://www.imarcgroup.com/cell-analysis-market/requestsample

 

Cell analysis is used in academic institutions, hospitals, and biotechnology fields for studying stem cells, immunology, neurology, non-invasive prenatal diagnosis, and in-vitro fertilization. This, in confluence with the increasing prevalence of chronic diseases, represents one of the key factors bolstering the market growth. Apart from this, key players are introducing advanced sensors and microscopes and fast detection kits, which are multifunctional and help detect diseases in real-time. This, along with easy access to healthcare facilities, is anticipated to drive the market. Looking forward, IMARC Group expects the cell analysis market to reach US$ 28.8 Billion by 2027, exhibiting a CAGR of 8.97% during 2022-2027.

 

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

 

Competitive Landscape with Key Players:

  • Agilent Technologies Inc.
  • BD Biosciences
  • Bio-RAD Laboratories Inc.
  • Danaher Corporation
  • Illumina Inc.
  • Merck KGaA
  • Miltenyi Biotec
  • Olympus Corporation
  • PerkinElmer Inc.
  • Promega Corporation
  • Sysmex Corporation
  • Thermo Fisher Scientific

Market Segmentation:

 

Breakup by Product:

  • Flow Cytometry Products
  • qPCR Products
  • Cell Microarrays
  • Microscopes
  • Spectrophotometers
  • Cell Counters
  • HCS Systems
  • Others

Breakup by Analysis Type:

  • Cell Identification
  • Cell Viability
  • Cell Signaling Pathways/Signal Transduction
  • Cell Proliferation
  • Cell Counting and Quality Control
  • Cell Interaction
  • Target Identification and Validation
  • Single-Cell Analysis
  • Others

Breakup by Techniques:

  • Molecular Approaches
  • Image-Based Approaches

Breakup by End-User:

  • Pharmaceutical and Biotechnology Companies and CROs
  • Hospitals and Diagnostic Laboratories
  • Research Institutes
  • Cell Culture Collection Repositories
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/cell-analysis-market

 

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

 

Related Reports by IMARC Group:

Trauma Care Centers Market: https://www.imarcgroup.com/trauma-care-centers-market

Laboratory Proficiency Testing Market: https://www.imarcgroup.com/laboratory-proficiency-testing-market

Extracorporeal Membrane Oxygenation Machine Market: https://www.imarcgroup.com/extracorporeal-membrane-oxygenation-machine-market

Medical Tapes and Bandages Market: https://www.imarcgroup.com/medical-tapes-bandages-market

Oligonucleotide Synthesis Market: https://www.imarcgroup.com/oligonucleotide-synthesis-market

 

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

 

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA - Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: - +1 631 791 1145 | Africa and Europe: - +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities